Hilltop National Bank’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Hold
686
0.05% 216
2026
Q1
$172K Buy
686
+213
+45% +$53K 0.04% 258
2025
Q4
$130K Hold
473
0.03% 291
2025
Q3
$124K Buy
473
+180
+61% +$43.7K 0.03% 314
2025
Q2
$64.1K Buy
+293
New +$62.6K 0.02% 419
2024
Q4
$70.8K Buy
216
+70
+48% +$22K 0.02% 382
2024
Q3
$43.8K Sell
146
-7
-5% -$2.14K 0.01% 482
2024
Q2
$50.4K Buy
153
+5
+3% +$1.77K 0.02% 456
2024
Q1
$58.6K Buy
+148
New +$54.7K 0.02% 422

Other funds holding WST

Hilltop National Bank's WST Position: Q2 2026 in Review

Hilltop National Bank held its West Pharmaceutical (WST) position steady in Q2 2026 at 686 shares worth $246K. The position accounts for 0.05% of the portfolio, ranked #216.

Hilltop National Bank first reported a position in WST in Q1 2024 and has held it in 9 quarters since. 167 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Hilltop National Bank held 686 shares of West Pharmaceutical worth $246K as of Q2 2026.
  • Hilltop National Bank left its West Pharmaceutical share count unchanged in Q2 2026.
  • West Pharmaceutical made up 0.05% of Hilltop National Bank's portfolio in Q2 2026, its #216 holding.
  • Hilltop National Bank first reported a position in West Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • 167 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.